EXTL3
Basic information
Region (hg38): 8:28600469-28756561
Links
Phenotypes
GenCC
Source:
- immunoskeletal dysplasia with neurodevelopmental abnormalities (Strong), mode of inheritance: AR
- immunoskeletal dysplasia with neurodevelopmental abnormalities (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunoskeletal dysplasia with neurodevelopmental abnormalities | AR | Allergy/Immunology/Infectious | The condition can include severe combined immunodeficiency, and awareness may allow preventive measures and early and aggressive treatment of infections | Allergy/Immunology/Infectious; Musculoskeletal; Neurologic | 28148688; 28132690 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (485 variants)
- Inborn_genetic_diseases (101 variants)
- EXTL3-related_disorder (11 variants)
- Immunoskeletal_dysplasia_with_neurodevelopmental_abnormalities (11 variants)
- not_specified (1 variants)
- Familial_meningioma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EXTL3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001440.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 223 | 233 | ||||
missense | 246 | 256 | ||||
nonsense | 7 | |||||
start loss | 1 | 1 | ||||
frameshift | 5 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
Total | 1 | 2 | 259 | 232 | 9 |
Highest pathogenic variant AF is 0.000008673328
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EXTL3 | protein_coding | protein_coding | ENST00000220562 | 5 | 155131 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000250 | 0.999 | 125722 | 0 | 26 | 125748 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.48 | 458 | 556 | 0.824 | 0.0000394 | 6005 |
Missense in Polyphen | 91 | 176.92 | 0.51436 | 1866 | ||
Synonymous | -1.29 | 259 | 234 | 1.11 | 0.0000165 | 1919 |
Loss of Function | 2.94 | 13 | 30.5 | 0.426 | 0.00000172 | 346 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000167 | 0.000167 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Glycosyltransferase which regulates the biosynthesis of heparan sulfate (HS). Important for both skeletal development and hematopoiesis, through the formation of HS proteoglycans (HSPGs) (PubMed:28132690, PubMed:28148688). Required for the function of REG3A in regulating keratinocyte proliferation and differentiation (PubMed:22727489). {ECO:0000269|PubMed:22727489, ECO:0000269|PubMed:28132690, ECO:0000269|PubMed:28148688}.;
- Pathway
- Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human);XBP1(S) activates chaperone genes;heparan sulfate biosynthesis (late stages);heparan sulfate biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.177
Intolerance Scores
- loftool
- 0.0851
- rvis_EVS
- -1.79
- rvis_percentile_EVS
- 2.24
Haploinsufficiency Scores
- pHI
- 0.349
- hipred
- Y
- hipred_score
- 0.575
- ghis
- 0.490
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.700
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Extl3
- Phenotype
- endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- extl3
- Affected structure
- retinal ganglion cell
- Phenotype tag
- abnormal
- Phenotype quality
- organization quality
Gene ontology
- Biological process
- protein glycosylation;heparan sulfate proteoglycan biosynthetic process;positive regulation of cell growth;IRE1-mediated unfolded protein response
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;integral component of membrane
- Molecular function
- glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity;transferase activity, transferring glycosyl groups;metal ion binding